The US Food and Drug Administration (FDA) has granted 510(k) clearance to Carticept Medical's new computer-controlled injection system.
The new Navigator Delivery System (DS) is designed to increase the efficiency, comfort, safety and accuracy of musculoskeletal injections for the treatment of Arthritis.
The system also offers optional integration with ultrasound imaging to improve the accuracy of intra-articular injections and integrates multiple new software features to improve further office and workflow efficiency.
Carticept Medical president and chief executive officer Timothy Patrick said improving patient safety and office workflow are two significant issues facing healthcare today.
"We believe that the Navigator DS' computer-controlled preparation, delivery and recordkeeping of these medications addresses these issues with technology that will change the current standard of care," Patrick added.
"We are aggressively pursuing development of our technology's use in the rapidly growing anesthetic nerve block application and look forward to bringing that product to the market in the near future."
